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Bridging the Divide
EDITORIAL
The theme for the 2014 congress “Bridging the Divide” was selected to highlight the idea that 
improving the overall health of a population requires partnerships and interdependence with structures 
within and outside the healthcare domain. A health care delivery system is thought to account for 
around 10% of preventable deaths with the remainder attributable to social and environmental 
determinants, personal behaviour and genetic predisposition.(1) This interdependence comes from the 
knowledge that increased life expectancy, on the one hand due to a reduction in premature mortality 
from improved sanitation, nutrition and vaccinations in the childhood years, at the other end is linked 
to the health and survival of the elderly due to innovations in science and technology. 
Population ageing, whereby older individuals make up increasingly larger numbers in a given society, is 
a demographic trend worldwide that is not confined to the affluent nations. While we acknowledge 
the importance of investing resources in the childhood years, the healthcare and survival of the elderly 
has also become a pressing need. In addition, the population in the “middle years”, realising the 
potential of a long life, look to physicians to increase their “health-span”, i.e. the years of healthy living 
before the eventual decline sets is. Therefore, although as physicians our traditional role has been the 
treatment of disease, there is a growing acceptance that we need to be equally engaged in the 
preservation of health.   
As developments in molecular science continue to unravel the complexities of the ageing process, 
there is increasing recognition that the common age-related disorders which include atherosclerotic 
cardiovascular disease, diabetes, cancer and Alzheimers disease, share a common biology. A growing 
body of evidence suggests that these disorders and the environmental risk factors that drive them, are 
associated with progressive DNA damage, which acts via a molecular circuit involving telomeres-p53-
mitochondria and impacts on several signaling pathways to drive the ageing process. While this 
knowledge has led to the exploration of novel anti-senescence therapies for disease states, the quest 
for delaying physiological ageing as well as further extending human lifespan has gained unprecedented 
attention, so much so that venture capitalist companies including Google and Apple, have joined forces 
to make significant investments in the science of biogerontology.
However, while we endeavour to increase the lifespan of octo- and nona-genarians, we simultaneously 
grapple with diseases linked to a lack of basic amenities. While, as a society, we adopt guidelines of 
developed nations and hope to emulate their standards of care, our population, resources and 
geography dictate a different dictum. While we are quick to introduce high-end technologies for 
treating well-known diseases such as hypertension and heart failure, there remains disarray in basic 
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definitions and disagreement amongst experts and guideline-writing committees on treatment pro-
tocols. Nowhere is this divide more evident than in the confusion that is being witnessed regarding 
fundamental issues of what constitutes a heart healthy diet or appropriate exercise regimens that 
know the balance between endurance and resistance training. It is therefore understandable that there 
exists a thriving industry, shrouded in pseudo-science and without the requirements of scientific data and 
regulatory jurisdiction, advocating untested diets and offering a multitude of products such as anti-
oxidants to neutralise free radicals, chelators to bind heavy metals, dehydroepiandrosterone to strengthen 
the immune system, growth hormone to increase muscle mass and a plethora of nutriceuticals to delay 
the ageing process. Indications are that while the more affluent sectors of our community appear to be 
succumbing to this subterfuge, the less privileged are even more vulnerable as they are undergoing not 
only a nutritional transition to the calorie-loaded fast-food-industry diets but are also falling victim to this 
marketing. This population who are dependent upon, and likely disillusioned with our ailing healthcare 
system, may be more susceptible to these ‘alternative purveyors’ of healthcare.
The planning of sessions and selection of topics for the congress were chosen to address some of these 
issues with the intention to bridge the divide between scientist and clinician, physician and surgeon, 
doctor and allied health professional, the industry vendor and the healthcare consumer, as well as 
between the state and private practitioner. Though we appear to come from dichotomous positions, 
acting from the vantage point of our specific field of interest, as several colleagues writing for these 
editorial pages have previously indicated, the future wellbeing of our patients as well as our discipline 
dictate that we create meaningful engagements and foster collaborative partnerships. Writing from the 
perspective of a state employee and to counter the prevailing pessimism descending into nihilism, it is 
instructive to heed the advice of the world’s most foremost philanthropist “By almost any measure, the 
world is better than it has ever been…. The belief that the world can't solve poverty and disease isn't 
just mistaken, it is harmful.” (Bill Gates January 2014).
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